Company
Emedgene
Unlock genomic insights for hereditary disease
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Customers
- labs
Claim, correct or request removal
Record updated 20 September 2026
About
Emedgene variant interpretation software streamlines your tertiary analysis workflows for rare disease and germline screening research applications
Products
- Web
- Emedgene
Loading relationship preview